Results
1 -
2 of
2Management of Resistance to First-Line Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor Therapy, Current Treatment Options in Oncology Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review, Journal of Hematology & Oncology